{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:11:39Z","timestamp":1777929099208,"version":"3.51.4"},"reference-count":68,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a complex etiology. Interleukin-18 (IL-18) possesses pro-inflammatory properties and plays a central role in the development of SLE. In this study, we assessed the association between two functional variants that affect the expression of\n                      <jats:italic toggle=\"yes\">IL-18<\/jats:italic>\n                      , namely \u2212607C &gt; A (rs1946518) and \u2212137G &gt; C (rs187238), and the risk of SLE development.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>As a case-control study, 251 peripheral blood samples were collected from 121 SLE patients and 130 healthy participants. Genotyping of these polymorphisms was performed using the high-resolution melting (HRM) method, which employs real-time polymerase chain reaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings revealed a significant association between the AA genotype and A allele in rs1946518, showing a decreased risk of SLE (AA vs CC; OR: 0.386; 95% CI [0.174\u20130.828], A vs C; OR: 0.548; 95% CI [0.369\u20130.809]). Analogously, the CC genotype and C allele in rs187238 exhibited a similar trend (CC vs GG; OR: 0.240; 95% CI [0.055\u20130.803], C vs G; OR: 0.604; 95% CI [0.390\u20130.928]), indicating a reduced risk of SLE Moreover, SLE subjects with the protective allele in rs1946518 (AA + AC) demonstrated significantly lower levels of CRP, and Anti-dsDNA, suggesting lower disease activity. These patients also had a later age of onset, and a lower incidence of renal involvement and creatinine levels, indicating milder disease severity (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt;\n                      <jats:italic toggle=\"yes\">.05<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The study indicates a significant relationship between the rs1946518 and rs187238 variants in\n                      <jats:italic toggle=\"yes\">IL-18<\/jats:italic>\n                      and a reduced risk of SLE. Furthermore, rs1946518 was found to be associated with certain clinical features related to disease activity and severity.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033251331256","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:38:05Z","timestamp":1743255485000},"page":"579-587","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Significant association of functional variants in the promoter sequence of\n                    <i>IL18<\/i>\n                    with disease susceptibility and systemic lupus erythematosus clinical parameters"],"prefix":"10.1177","volume":"34","author":[{"given":"Yousef","family":"Mohammadi","sequence":"first","affiliation":[{"name":"Student Research Committee, University of Social Welfare and Rehabilitation Sciences"},{"name":"Hope Generation Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mozhdeh","family":"Saghaei","sequence":"additional","affiliation":[{"name":"Isfahan University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Saghi","sequence":"additional","affiliation":[{"name":"Student Research Committee, University of Social Welfare and Rehabilitation Sciences"},{"name":"Hope Generation Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Amirhosein","family":"Mazhari","sequence":"additional","affiliation":[{"name":"Student Research Committee, Azerbaijan Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrang","family":"Alani","sequence":"additional","affiliation":[{"name":"Kashan University of Medical Sciences"},{"name":"Kashan University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeim","family":"Ehtesham","sequence":"additional","affiliation":[{"name":"Iranshahr University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiebe","family":"Kenarangi","sequence":"additional","affiliation":[{"name":"Student Research Committee, University of Social Welfare and Rehabilitation Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-9464","authenticated-orcid":false,"given":"Mohsen","family":"Soosanabadi","sequence":"additional","affiliation":[{"name":"Semnan University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"e_1_3_4_2_2","volume-title":"Distinct clinical manifestations associated with autoantibodies and cytokines in systemic lupus erythematosus","author":"Alduraibi FK","year":"2022","unstructured":"Alduraibi FK. Distinct clinical manifestations associated with autoantibodies and cytokines in systemic lupus erythematosus. Birmingham, AL: The University of Alabama at Birmingham, 2022."},{"issue":"10","key":"e_1_3_4_3_2","first-page":"e30330","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer MA","year":"2022","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 2022; 14(10): e30330.","journal-title":"Cureus"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59061033"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05346-x"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac695"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222345"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa030"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2023.02.014"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-021-00758-0"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147666"},{"key":"e_1_3_4_12_2","first-page":"303","article-title":"Investigation of rs531564 polymorphism in the primary microRNA-124 gene in patients with systemic lupus erythematosus and rheumatoid arthritis: association with disease susceptibility and clinical characteristics","volume":"20","author":"Hassani M","year":"2021","unstructured":"Hassani M, Dehani M, Zare Rafie M, et al. Investigation of rs531564 polymorphism in the primary microRNA-124 gene in patients with systemic lupus erythematosus and rheumatoid arthritis: association with disease susceptibility and clinical characteristics. Iran J Allergy Asthma Immunol 2021; 20: 303\u2013313.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00763"},{"key":"e_1_3_4_15_2","first-page":"6672987","article-title":"Research article interleukin-18 in Brazilian rheumatoid arthritis patients: can leflunomide reduce it?","volume":"1","author":"Cardoso PRG","year":"2021","unstructured":"Cardoso PRG, Marques CDL, de Melo Vilar K, et al. Research article interleukin-18 in Brazilian rheumatoid arthritis patients: can leflunomide reduce it? Autoimmune Dis 2021; 1: 6672987.","journal-title":"Autoimmune Dis"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0106-0"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-009-0036-2"},{"key":"e_1_3_4_18_2","first-page":"100","article-title":"The impact of functional promoter variants in interleukin-18 on susceptibility to rheumatoid arthritis in Iranian population","volume":"13","author":"Ramezanzadeh M","year":"2024","unstructured":"Ramezanzadeh M, Khodabandehloo F, Alesaeidi S, et al. The impact of functional promoter variants in interleukin-18 on susceptibility to rheumatoid arthritis in Iranian population. Adv Biomed Res 2024; 13: 100.","journal-title":"Adv Biomed Res"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030100240"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.02.006"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.12.012"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.2.287"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20272"},{"key":"e_1_3_4_24_2","first-page":"504","article-title":"Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation","volume":"9","author":"Naftali T","year":"2007","unstructured":"Naftali T, Novick D, Gabay G, et al. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation. IMAJ-RAMAT GAN 2007; 9: 504\u2013508.","journal-title":"IMAJ-RAMAT GAN"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200203001-00010"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04742.x"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84170-4"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2020.27.2.110"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(00)00407-0"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2011.1221"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12616"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2007.08.009"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2018.04.001"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00766.x"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1107830108"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.9.5338"},{"key":"e_1_3_4_38_2","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito APN","year":"2007","unstructured":"Lotito APN, Campa A, Silva CA, et al. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 2007; 34: 823\u2013830.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1155\/MI.2005.273"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/13547500600565735"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/13547500802033300"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2009.12482"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0029-8"},{"key":"e_1_3_4_44_2","first-page":"156890","article-title":"IL\u201018 serum level in adult onset still\u2019s disease: a marker of disease activity","volume":"2012","author":"Colafrancesco S","year":"2012","unstructured":"Colafrancesco S, Priori R, Alessandri C, et al. IL\u201018 serum level in adult onset still\u2019s disease: a marker of disease activity. Int J Inflamm 2012; 2012: 156890.","journal-title":"Int J Inflamm"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei266"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03180.x"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1021409"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.21608\/jesp.2019.68297"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01989.x"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01250"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.10.1078"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.4103\/1110-161X.147358"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2013.67.237-240"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02588.x"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.15171\/jnp.2016.05"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2012.09.005"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00913.x"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16024180"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.4172\/2576-1420.1000117"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22345"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-2344-y"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-13-107"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-014-3723-3"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308094559"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000364"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319834677"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-1036-4"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2019.1710831"},{"key":"e_1_3_4_69_2","first-page":"1","article-title":"Interleukin-18 gene polymorphisms in systemic lupus erythematosus: relation to disease status","volume":"21","author":"Fouad NA","year":"2014","unstructured":"Fouad NA, Baraka EA, Hassan WA. Interleukin-18 gene polymorphisms in systemic lupus erythematosus: relation to disease status. Egypt J Immunol 2014; 21: 1\u201312.","journal-title":"Egypt J Immunol"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251331256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033251331256","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251331256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:28:51Z","timestamp":1777678131000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033251331256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/09612033251331256"],"URL":"https:\/\/doi.org\/10.1177\/09612033251331256","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}